Cargando…
COVID-19: the role of excessive cytokine release and potential ACE2 down-regulation in promoting hypercoagulable state associated with severe illness
The novel coronavirus disease (COVID-19) has become a universally prevalent infectious disease. The causative virus of COVID-19 is severe acute respiratory syndrome coronavirus type 2. Recent retrospective clinical studies have established a significant association between the incidence of vascular...
Autores principales: | Du, Fenghe, Liu, Bao, Zhang, Shuyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7365308/ https://www.ncbi.nlm.nih.gov/pubmed/32676883 http://dx.doi.org/10.1007/s11239-020-02224-2 |
Ejemplares similares
-
COMPARMENT SYNDROME: AN UNSUSPECTED CONSEQUENCE OF HYPERCOAGULABLE STATE IN A PATIENT WITH SEVERE COVID-19 ILLNESS
por: SIDDIQUI, SABRINA, et al.
Publicado: (2021) -
The hypercoagulable states in anaesthesia and critical care
por: Bande, Bala D, et al.
Publicado: (2014) -
Serum hypercoagulability states in Coats’ disease
por: Ghassemi, Fariba, et al.
Publicado: (2017) -
Treatment of hypercoagulation state in acute myocardial infarction
por: Kreines, VM, et al.
Publicado: (1998) -
HYPERCOAGULABLE STATE: AN ENIGMA IN COVID-19 INFECTION
por: MILI, SAIMA, et al.
Publicado: (2021)